Mechanism of Action of Apalutamide
Introduction Apalutamide is an oral targeted anticancer drug marketed under the brand name Erleada. Pharmacologically, apalutamide is an androgen receptor inhibitor used in prostate cancer. Prostate cancer growth is often driven by androgen signaling. Androgens such as testosterone and dihydrotestosterone bind to androgen receptors inside prostate cancer cells. Once activated, androgen receptors move into the … Read more